Why Netanyahu Is Being Questioned for Hiding His Cancer and Why So Many Others Do the Same

On 24 April 2026, Israeli Prime Minister Benjamin Netanyahu announced on social media that he had been diagnosed with early-stage prostate cancer, treated with targeted radiation therapy, and was now in full remission. The announcement was unusual not for what it disclosed but for what it admitted withholding. Netanyahu had known about the diagnosis for two months. He had kept the information private, he said, to prevent Iran from using it as wartime propaganda. The reaction was swift. Critics questioned the delay, the timing relative to a pending pardon in his corruption trial, and the broader question of what a head of state owes the public about his own body.Also Read: How Gauhar Jaan Became the First Indian Recording Artist Heard Around

the World

The Public Figure's Particular Bind

Netanyahu's situation is not the same as that of an ordinary patient. A serving prime minister at war has obligations to disclose serious illness that a private citizen does not. His critics are right to interrogate the timing. But the smaller, more human question underneath the political one is worth pausing on. Even at seventy-six, even with a personal physician and the resources of the Israeli state, Netanyahu hesitated to say the word cancer in public. He is not unusual in that. Most people who receive a cancer diagnosis spend at least some time deciding who to tell, when, and how. Many decide, at first, not to tell anyone at all.

The Reasons People Stay Silent

Research on cancer disclosure has identified a remarkably consistent set of reasons. A 2024 Oxford Academic monograph on cancer stigma, drawing on patient testimonies from the United States, Indonesia, Morocco and elsewhere, found that fear of being treated differently was the most commonly cited reason for keeping a diagnosis private. Patients spoke of not wanting to become, as one survivor put it, "the cancer person" in every room they entered. Others described a fear of pity that was almost stronger than the fear of the illness itself.

Family protection is the second most cited reason. A study of cancer patients at Seattle Cancer Care Alliance, led by oncologist Bart Scott, found that men in particular often ask doctors not to share their diagnosis with their wives or children, in the belief that they are sparing their families pain. Scott's clinical observation, supported by his colleague Jesse Fann in psychiatry, is that this almost always backfires. The mystery, they note, causes more stress than the truth would have.

The Specific Stigma of Specific Cancers

Not all cancers carry the same weight of silence. Lung cancer carries a stigma of self-blame because of its association with smoking. HPV-related cancers, including oropharyngeal, cervical and anal cancers, carry a stigma that draws assumptions about sexual history. In a 2023 qualitative study published in the National Library of Medicine, patients with these cancers reported significantly lower rates of disclosure to friends and colleagues than patients with breast or prostate cancer.Prostate cancer, the disease Netanyahu was treated for, carries its own quieter stigma. Treatment can affect urinary continence and sexual function. Many men, even those who would discuss other illnesses openly, simply do not want to have those conversations.

What the Indian Research Reveals

The Indian picture is starker than the Western one, and for different reasons. A 2012 study by researchers at IIT Hyderabad, published in Psycho-Oncology, surveyed 329 Indian cancer patients and found that 54.1 per cent of them were unaware of their own diagnosis. The decision had been made for them, almost always by family members in collusion with treating oncologists. A subsequent qualitative study published in the BMJ in 2019, based on interviews with patients, families and clinicians at a tertiary teaching hospital in South India, described the practice plainly. The common clinical approach, the authors wrote, was to withhold information from patients, or to actively give an inaccurate account, perpetuating the stigma of discussing death within medical and lay discourse.

A 2020 survey of 250 patients and 250 caregivers, published in JCO Global Oncology, found something the families and oncologists had not expected. When Indian patients were finally asked what they wanted, the majority said they wanted to know. They wanted to know the treatment options, the side effects, the prognosis, and the expected length of survival. The protective silence around them was not what they had asked for. It was what had been chosen on their behalf.The cost of that silence is not abstract. A North Indian study published in 2017 found that Indian cancer patients waited an average of 271 days between noticing their first symptoms and telling a friend or family member about them. Nine months. The delay shows up in survival statistics. Cancers caught early are far more treatable than cancers caught late. In a country where stigma still includes the belief that the person somehow brought the illness upon themselves, often through karmic transgression in a previous life, the silence is not merely cultural. It is medically dangerous.

What Netanyahu's Disclosure Does Not Settle

The political questions around Netanyahu's two-month delay are legitimate and ongoing. They will be argued through the Israeli election cycle and beyond. The smaller, more human question his disclosure raises is one most readers will recognise. Almost everyone who has received a cancer diagnosis, or sat beside someone who has, knows the silence that follows. It is rarely about secrecy in any straightforward sense. It is about not yet having the words, not yet being ready, not yet wanting to become a person to whom this is happening. The delay is human. The judgment of others, often, is not.Also Read: The Forgotten Indian Pioneer Who Introduced Shampoo to Britain in 1814If you are reading this because someone you love has gone quiet on their own diagnosis, or because you yourself have, the research is unusually clear on one point. People wait to tell because they think silence protects the people around them. It rarely does. The studies, across countries and cancer types, find that disclosure usually relieves more than it costs, both for the patient and for those they love. In India, in particular, where families and doctors often decide for the patient, the most radical thing you can do is simply ask the person what they want to know. They will usually tell you. When you are ready, tell someone. The right person, in the right way, at your own pace. That is the only deadline worth keeping.